☆ 4.5 Article

Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort

VIROLOGY JOURNAL (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021

Tyng-Yuan Jang et al.

Summary: This study provides a detailed description of the clinical characteristics of Delta variant COVID-19 and the treatment outcome of antiviral agents in Pingtung County, Taiwan. The study found that risk factors for pneumonia included high levels of serum AST, ferritin, and LDH.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Urology & Nephrology

SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis

Ilias Bensouna et al.

Summary: The effectiveness of a third dose of the BNT162b2 vaccine in patients undergoing dialysis treatment was investigated, and it was found that the third dose significantly increased antibody levels.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

Ole Schmeltz Sogaard et al.

Summary: This study aimed to identify individual characteristics associated with the effectiveness and durability of COVID-19 vaccines. The study found that comorbidity, male sex, vaccine type, and age ≥75 years were associated with a lower response to the vaccine and a lack of durable antibody response. Vaccine-induced antibodies had declined to pre-second-vaccination levels for most individuals after 6 months.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients

Yana Davidov et al.

Summary: Liver transplant recipients showed significantly improved immune response after receiving a third dose of the BNT162b2 mRNA vaccine. The majority of patients developed sufficient humoral and cellular immune responses. Older age and immunosuppressive medications were predictive factors for non-response.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Letter Medicine, General & Internal

Why cannot Taiwan be COVID-19 free?

Tyng-Yuan Jang

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Virology

Antibody titers after a third dose of the SARS-CoV-2 BNT162b2 vaccine in immunocompromised adults in Greece: Is a fourth dose necessary?

Konstantina Kontopoulou et al.

Summary: Real-world data suggests that protection against COVID-19 declines a few months after vaccination, especially in the elderly and immunocompromised individuals. This study aimed to analyze the humoral response induced by a third supplemental dose of the BNT162b2 vaccine in immunocompromised individuals. The results showed a significant increase in overall IgG antibody titers four weeks after the third vaccine dose, regardless of underlying conditions, age, sex, or the number of days between the second and third dose.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Letter Medicine, General & Internal

Liver injury caused by SARS-CoV-2 Delta and Omicron-variant in Taiwan

Tyng-Yuan Jang

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19

Fuhai Li et al.

Summary: Sex is an important factor associated with COVID-19 mortality. Estrogen, interacting with ESR1/2 receptors, protects COVID-19 patients from death by inhibiting inflammation and immune response caused by SARS-CoV-2 infection. A high level of estradiol in young female COVID-19 patients contributes to their protection, while a decrease in estrogens after about 55 years of age leads to an increased fatality rate in women.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Immunology

Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines

Tomabu Adjobimey et al.

Summary: The study suggests that Moderna's vaccine is most effective in inducing SARS-CoV-2 specific neutralizing antibodies, while individuals vaccinated with vaccines from Sinopharm and Johnson and Johnson showed lower antibody titers. The lack of significant increase in neutralizing antibodies in elderly individuals after vaccination is a concern. Heterologous vaccination strategies may be more effective than homologous counterparts.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Health Care Sciences & Services

Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination

Roberto Cangemi et al.

Summary: This study aimed to explore the relationship between mRNA vaccine-induced antibodies and gender-sensitive variables among healthcare workers. The findings suggest that demographic, clinical, and social variables play a role in the decrease of antibody levels and should be considered in personalized vaccination schedules.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

Alessandra Vergori et al.

Summary: HIV-infected individuals showed a strong humoral response after the third dose of a SARS-CoV-2 vaccine, while their cell-mediated immunity remained stable. This study highlights the usefulness of a third vaccine dose in people living with HIV who are on suppressive antiretroviral therapy.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Thomas Marjot et al.

Summary: This international registry study demonstrates that patients with cirrhosis are at increased risk of death from COVID-19. Mortality from COVID-19 was particularly high among patients with more advanced cirrhosis and those with alcohol-related liver disease.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Letter Public, Environmental & Occupational Health

222 days without COVID in Taiwan: what are the reasons for this success?

Chia-Yen Dai et al.

Summary: The second wave of COVID-19 has emerged in multiple countries, including Vietnam, after a period of 99 days without further local transmission since the first wave. Meanwhile, Taiwan has successfully kept no indigenous cases of COVID-19 for 222 days.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Mix-and-match COVID vaccines ace the effectiveness test

Ewen Callaway

NATURE (2021)

添加到收藏夹

Review Infectious Diseases

What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2

Susanne H. Hodgson et al.

Summary: The development of a vaccine for the novel coronavirus is crucial to prevent the spread of the pandemic and reduce disease mortality. The efficacy endpoint is protection against severe disease and death, but evaluating this in phase 3 clinical trials poses challenges.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021

Kristina L. Bajema et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Medicine, General & Internal

Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection

Do Hyoung Kim et al.

Summary: Patients with comorbidities and advanced age have a higher mortality rate and worse clinical outcomes when infected with COVID-19. This study suggests that the age-adjusted Charlson comorbidity index score (CCIS) is an important predictor for patient mortality and clinical outcome.

MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

Joseph E. Ebinger et al.

Summary: Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals. Post-vaccine symptoms were more prominent for those with prior infection after the first dose, but symptomology was similar between groups after the second dose.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting

Adeel A. Butt et al.

Summary: The study evaluated the short-term effectiveness of SARS-CoV-2 vaccines in preventing infection in a real-world setting. The results showed that the currently used vaccines are highly effective in preventing confirmed infection in a high-risk population, whether it is the Pfizer-BioNTech BNT-162b2 vaccine or the Moderna mRNA-1273 vaccine.

ANNALS OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Microbiology

Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greek healthcare workers

Konstantina Kontopoulou et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

COVID-19 in early 2021: current status and looking forward

Chengdi Wang et al.

Summary: Since the first description of a coronavirus-related pneumonia outbreak in December 2019, the virus SARS-CoV-2 has evolved into a pandemic, affecting over 100 million people globally. This review summarized the current knowledge in epidemiology, virology, diagnosis, treatment, and vaccine development, providing specific dates for key developments. The world is working together to combat this pandemic, highlighting the rapid evolution of research and development in these areas.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Virology

Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2

Shih-Cheng Chen et al.

Summary: By performing structural phylogenetic analysis, a variety of repetitive structural motifs (RSMs) have been identified in almost all CoV genomic RNAs, mainly located in the 5'-UTRs and inter-domain regions of polyprotein 1ab coding sequences.

VIRUS EVOLUTION (2021)

添加到收藏夹

Article Virology

Structural phylogenetic analysis reveals lineage-specific RNA repetitive structural motifs in all coronaviruses and associated variations in SARS-CoV-2

Shih-Cheng Chen et al.

Summary: RSMs are present in almost all CoV genomic RNAs, located exclusively in the 5'-UTRs and/or in the inter-domain regions of poly-protein lab coding sequences in a lineage-specific manner. Different types of RSMs were found in different CoV lineages, suggesting their fundamental roles in the CoV life cycle.

VIRUS EVOLUTION (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Response to COVID-19 in Taiwan Big Data Analytics, New Technology, and Proactive Testing

C. Jason Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Review Medicine, General & Internal

The outbreak of COVID-19: An overview

Yi-Chi Wu et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

添加到收藏夹

Review Health Care Sciences & Services

Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic

Jennifer Summers et al.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.